Literature DB >> 24513132

Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.

Shahin Najar Peerayeh1, Rahim Pirhajati Mahabadi2, Sanaz Pakbaten Toupkanlou3, Seyed Davar Siadat4.   

Abstract

INTRODUCTION: The emergence of imipenem non-susceptible Pseudomonas aeruginosa isolates is a matter of great concern because these isolates can become resistant to all available antibiotics. This study conducted to characterize β-lactamase genes in imipenem resistant P. aeruginosa isolates from bloodstream.
METHODS: 56 non-duplicate clinical isolates of P. aeruginosa were collected in Tehran hospitals. Antibacterial susceptibility was determined by disk diffusion and MIC methods. ESBL and MBL production was confirmed by combined disk. β-Lactamase classes A, B and D genes were identified by PCR.
RESULTS: Seventeen (30.3%) isolates were imipenem resistant for which 16 isolates simultaneously were resistant to all tested antibiotics. While among 39 imipenem susceptible isolates, only two isolates were resistant to all tested antibiotics. In imipenem resistant isolates, blaTEM, blaSHV and blaOXA-10 were found in 41.1% of isolates and blaVIM, blaIMP and blaPER were identified in 47%, 11.7% and 5.8% of isolates respectively, while in imipenem susceptible isolates, blaTEM, blaSHV and blaOXA-10 were determined in 2.5%, 7.6% and 33.3% of isolates, respectively. The imipenem resistant isolates had been recovered mostly (67.7%) from patients in the Burn hospital.
CONCLUSION: The result of this study indicated the emergence of multidrug resistant MBL and non-MBL producing P. aeruginosa, particularly in the Burn hospital and blaVIM was dominant β-lactamase genes in imipenem resistant isolates. The isolation of carrier patients may lead to prevent a further dissemination.
Copyright © 2014 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Metallo β-lactamase; Pseudomonas aeruginosa; bla(OXA-10); bla(SHV); bla(TEM)

Mesh:

Substances:

Year:  2014        PMID: 24513132     DOI: 10.1016/j.burns.2014.01.009

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  5 in total

1.  WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.

Authors:  Bartolome Moya; Isabel M Barcelo; Sachin Bhagwat; Mahesh Patel; German Bou; Krisztina M Papp-Wallace; Robert A Bonomo; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.

Authors:  Diansy Zincke; Deepak Balasubramanian; Lynn L Silver; Kalai Mathee
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

3.  Biological characteristics of stem cells derived from burned skin-a comparative study with umbilical cord stem cells.

Authors:  Reinhard Dolp; Gertraud Eylert; Christopher Auger; Ayesha Aijaz; Yufei Andy Chen; Saeid Amini-Nik; Alexandra Parousis; Andrea-Kaye Datu; Marc G Jeschke
Journal:  Stem Cell Res Ther       Date:  2021-02-17       Impact factor: 6.832

4.  Genetic diversity and molecular analysis of metallo beta lactamases among imipenem resistant clinical isolates of Pseudomonas aeruginosa from Peshawar, Pakistan.

Authors:  Amjad Ali; Kafeel Ahmad; Shaista Rahat; Israr Ahmad
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

5.  Emerge of NDM-1-Producing Multidrug-Resistant Pseudomonas aeruginosa and Co-Harboring of Carbapenemase Genes in South of Iran.

Authors:  Ahmad Farajzadeh Sheikh; Mojtaba Shahin; Leili Shokoohizadeh; Fahimeh Ghanbari; Hamid Solgi; Fereshteh Shahcheraghi
Journal:  Iran J Public Health       Date:  2020-05       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.